Janus Henderson Investors
Status
ACTIVE
Global HQ
Denver, United States
Countries of investment
- United Kingdom
- United States
- Ireland
- Italy
- Netherlands
- Luxembourg
- United Arab Emirates
- Singapore
- Hong Kong
- Japan
- Australia
- China
- South Korea
- Taiwan
- Spain
- Germany
- Canada
- France
- Switzerland
- India
Investment stages
- Series A
- Series B
- Series C
- Growth
Industries
- Biotechnology
- Genomics
- Precision Medicine
About
Janus Henderson Investors delivers client-centric active management across global equities, fixed income, alternatives, and multi-asset strategies, prioritizing long-term performance through disciplined processes focused on stable cash flows, diversification, ESG integration, and innovation to achieve superior risk-adjusted returns.
Janus Henderson Investors delivers client-centric active management across global equities, fixed income, alternatives, and multi-asset strategies, prioritizing long-term performance through disciplined processes focused on stable cash flows, diversification, ESG integration, and innovation to achieve superior risk-adjusted returns.
Investment Thesis
Janus Henderson Investors manages diversified global portfolios across equities, fixed income, alternatives, and multi-asset strategies, emphasizing active management, risk discipline, and long-term value creation.
Manager's Experience
Managed by biotech-focused investors with strong scientific backgrounds in genomics, precision medicine, and translational research.
Team
Ali Dibadj - Chief Executive Officer
Roger Thompson - Chief Financial Officer
William Cassidy - Chief Technology Officer
Portfolio
Microsoft
Visa